STAAR Surgical Files Proxy Materials

TL;DR

STAAR Surgical sent out proxy materials on 9/19/25, shareholders need to pay attention.

AI Summary

STAAR Surgical Company filed a Definitive Additional Materials proxy statement on September 19, 2025, indicating they sent an email to shareholders via ProxyVote regarding company matters. The filing is a DEFA14A, which is a schedule for proxy statements.

Why It Matters

This filing indicates that STAAR Surgical Company is actively communicating with its shareholders about important company decisions or proposals through proxy statements, a standard practice for public companies.

Risk Assessment

Risk Level: low — This is a routine filing for a public company to provide shareholders with information for voting on corporate matters.

Key Players & Entities

• STAAR Surgical Company (company) — Registrant
• ProxyVote (company) — Distribution platform for shareholder communications
• 0001193125-25-209066 (filing_id) — Accession Number for the filing
• 20250919 (date) — Filing date

FAQ

Key Financial Figures

• $28.00 — ure you receive the compelling, premium $28.00 per share cash value afforded by the Al

Filing Documents

• d81363ddefa14a.htm (DEFA14A) — 28KB
• g81363g00s01.jpg (GRAPHIC) — 61KB
• g81363g00s02.jpg (GRAPHIC) — 223KB
• g81363g02n01.jpg (GRAPHIC) — 23KB
• g81363g02n02.jpg (GRAPHIC) — 23KB
• g81363g02n03.jpg (GRAPHIC) — 24KB
• g81363g03n03.jpg (GRAPHIC) — 28KB
• 0001193125-25-209066.txt ( ) — 524KB

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not -3- unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR's

Forward-looking statements speak only as of the date they are made and, except as may be required under

Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, STAAR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. -4-

View Full Filing

View this DEFA14A filing on SEC EDGAR